UBS AM’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
UBS AM's KLRA Position: Q3 2026 in Review
UBS AM opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 28,218 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #2897 among its holdings.
132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- UBS AM held 28,218 shares of Kailera Therapeutics worth $322K as of Q3 2026.
- Kailera Therapeutics was a new UBS AM position in Q3 2026.
- Kailera Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #2897 holding.
- 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.